Kow, CS, Zaidi, STR and Hasan, SS (2020) Cardiovascular Disease and Use of Renin-Angiotensin System Inhibitors in COVID-19. American Journal of Cardiovascular Drugs, 20 (3). pp. 217-221. ISSN 1175-3277
Abstract
There is ongoing debate on the safety of renin-angiotensin system (RAS) inhibitors in COVID-19. Recently published studies highlight a potential relationship between cardiovascular disease (CVD) and COVID-19. This article aims to summarize the evidence on the use of RAS inhibitors in CVD patients with COVID-19, focusing on safety issues of the RAS inhibitors and their relationship with COVID-19.
Metadata
| Authors/Creators: |
|
|---|---|
| Dates: |
|
| Institution: | The University of Leeds |
| Academic Units: | The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Healthcare (Leeds) > Pharmacy (Leeds) |
| Depositing User: | Symplectic Publications |
| Date Deposited: | 24 Sep 2020 08:46 |
| Last Modified: | 24 Sep 2020 08:46 |
| Status: | Published |
| Publisher: | Springer |
| Identification Number: | https://doi.org/10.1007/s40256-020-00406-0 |
Download not available
A full text copy of this item is not currently available from White Rose Research Online
CORE (COnnecting REpositories)
CORE (COnnecting REpositories)